Studies have extensively characterized the phenotypic features of HD 154 MSH2 003 mice. These mice exhibit a range of abnormalities, including:

The MSH2-003 mutation, in particular, has been linked to a rare genetic disorder known as hereditary nonpolyposis colorectal cancer (HNPCC). This condition is characterized by an increased risk of developing colorectal cancer, as well as other types of cancer.

: The model is instrumental in testing new therapeutic strategies, including gene therapy aimed at correcting genetic defects, and conventional chemotherapy and radiotherapy.

The Siberian Mouse HD 154 has become an invaluable tool for researchers studying the MSH2 gene and its role in human health. The mouse model has been used to study the effects of MSH2 mutations on genome stability and cancer development.

: It could be an entry in a database cataloging genetic information, samples, or experiments related to specific biological or medical research.

The future of the Siberian Mouse HD-154 (MSH2-003) and similar genetic models is bright, with potential applications extending beyond research into practical clinical use. As technology continues to evolve, we can expect to see: